Sf-RVN® Platform For Improving The Safety Profile Of Your Vaccines Process
Source: MilliporeSigma
The majority of Spodoptera frugiperda cells (such as Sf9) contain a rhabdovirus that is considered a process contaminant and must be eliminated during the bioprocess. With the Sf-RVN® Platform, we provide a rhabdovirus-free cell line that improves the safety profile of your vaccine processes combined with a chemically defined medium specifically formulated to get excellent growth and productivity. Combined, these two products form the Sf-RVN® Platform and provide a high performant rhabdovirus-free alternative to produce recombinant proteins and virus-like particles (VLP) for viral vaccines.
access the Brochure!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.
Subscribe to Outsourced Pharma
X
Subscribe to Outsourced Pharma
MilliporeSigma
This website uses cookies to ensure you get the best experience on our website. Learn more